ANVSVSIMDX• 7 Days (Normalized)
ANVS vs IMDX (Annovis Bio Inc. vs Insight Molecular Diagnostics Inc.)
Showing Closing Date Range from Sep, 04 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANVS Performance $1.12
-19.42%
Annovis Bio Inc.
Normalized Baseline0.00%
IMDX Performance $4.2
+1.69%
Insight Molecular Diagnostics Inc.
Normalized Baseline0.00%
Alpha Spread Margin IMDX LEADS
-21.11%
IMDX outperforming by 21.11%
ANVSIMDX
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANVS IMDX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | ANVS Price | ANVS Gain (%) | IMDX Price | IMDX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.12 | -19.42% | $4.20 | +1.69% | -21.11% |
| Sep 10, 2026 | $1.19 | -14.39% | $3.98 | -3.63% | -10.76% |
| Sep 09, 2026 | $1.22 | -12.23% | $4.10 | -0.73% | -11.50% |
| Sep 08, 2026 | $1.30 | -6.47% | $4.27 | +3.39% | -9.86% |
| Sep 04, 2026 | $1.39 | +0.00% | $4.13 | +0.00% | +0.00% |